Leonard Sank - Jan 3, 2022 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role: Director
Signature: /s/ Leonard Sank
Stock symbol: ORMP
Transactions as of: Jan 3, 2022
Transactions value $: $0
Form type: 4
Date filed: 1/5/2022, 07:52 PM
Next filing: Aug 1, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ORMP	Common Stock	Award		+6K			6K	Jan 3, 2022	Direct	F1
holding	ORMP	Common Stock						139K	Jan 3, 2022	By trust	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ORMP	Stock Option (right to buy)	Award	$0	+10K		$0.00	10K	Jan 3, 2022	Common Stock	10K	$13.89	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 1,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
F2	These shares consist of shares of common stock owned by a company wholly owned by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership of these shares.
F3	The Stock Option will vest in 4 installments as follows: 2,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.